Abstract
Background: Pulmonary tuberculosis (TB) and diffuse alveolar hemorrhage (DAH) have some commonalities in several parts of the world. However, acute hemoptysis with diffuse alveolar shadows while a patient is on anticoagulant and antiplatelet therapy for a specific reason suggests DAH over TB.
Case Presentation: In this case, a patient was presented with acute respiratory symptoms with hypoxia and bilateral alveolar shadows. He was treated for DAH at the initial encounter. However, on follow-up, he was confirmed having active pulmonary TB based on sputum acid-fast-bacilli culture.
Conclusion: He was successfully treated with standard first-line anti-tubercular therapy and was subsequently declared cured. Pulmonary DAH with TB, in the absence of an underlying autoimmune disorder, is rare.
Keywords: Pulmonary tuberculosis, Hemoptysis, Diffuse alveolar hemorrhage, Pulmonary artery stenosis, Clopidogrel, Rivaroxaban.
Related Books
Frontiers in Stem Cell and Regenerative Medicine Research
Frontiers in Clinical Drug Research - CNS and Neurological Disorders
Frontiers in Clinical Drug Research - Anti-Cancer Agents
Frontiers in Clinical Drug Research: Anti-Infectives
Frontiers in Anti-Infective Drug Discovery
Frontiers in Clinical Drug Research - CNS and Neurological Disorders
Coronaviruses
Recent Advances in Anesthesiology
Modern Occupational Diseases Diagnosis, Epidemiology, Management and Prevention
COVID-19: Effects in Comorbidities and Special Populations
3